|Articles|October 23, 2019
FDA Method for Determination of NDMA in Ranitidine
Author(s)VWR International Ltd
FDA recently posted an LC–HRMS method using the novel ACE3 C18-AR column, which can be used by regulators to detect “probable human carcinogen” NDMA in ranitidine.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Native Capillary Electrophoresis–Mass Spectrometry Enables Quantitative Profiling of Endogenous Protein Complexes
2
Event Preview: 2nd Green Analytical Chemistry Workshop
3
LC–MS Profiling Reveals Diet- and Hypertension-Specific Alterations in Amino Acid Metabolism
4
Best of the Week: Voices From the Analytical Front Line
5